Cargando…

Sirolimus Prolongs Survival after Living Donor Liver Transplantation for Hepatocellular Carcinoma Beyond Milan Criteria: A Prospective, Randomised, Open-Label, Multicentre Phase 2 Trial

Sirolimus (SRL) has been reported to benefit patients undergoing liver transplantation (LT) for hepatocellular carcinoma (HCC). This study aimed to compare SRL with tacrolimus (TAC) in living-donor LT (LDLT) recipients beyond the Milan criteria. This study was initially designed to enrol 45 recipien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Kwang-Woong, Kim, Seong Hoon, Yoon, Kyung Chul, Lee, Jeong-Moo, Cho, Jae-Hyung, Hong, Suk Kyun, Yi, Nam-Joon, Han, Sung-Sik, Park, Sang-Jae, Suh, Kyung-Suk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600292/ https://www.ncbi.nlm.nih.gov/pubmed/33053849 http://dx.doi.org/10.3390/jcm9103264

Ejemplares similares

Comparison of treatment outcome between living donor liver transplantation and sorafenib for patients with hepatocellular carcinoma beyond the Milan criteria
por: Cho, Yuri, et al.
Publicado: (2017)

Living donor liver transplantation should be cautiously considered as initial treatment in recurrent hepatocellular carcinoma within the Milan criteria after curative liver resection
por: Kim, Jong Man, et al.
Publicado: (2020)

Influence of Body Mass Index ≥30 on Pure Laparoscopic Donor Right Hepatectomy
por: Hong, Suk Kyun, et al.
Publicado: (2020)

Wearable recording video technology for surgical training in living donor liver transplantation
por: Lee, Shin Ae, et al.
Publicado: (2020)

Pure 3D laparoscopy versus open right hemihepatectomy in a donor with type II and III portal vein variations
por: Park, Kyungho, et al.
Publicado: (2019)

No diffuse intrahepatic biliary stricture after ABO-incompatible adult living donor liver transplantation using tailored rituximab-based desensitization protocol
por: Natsuda, Koji, et al.
Publicado: (2021)

Optimal Intervention for Initial Treatment of Anastomotic Biliary Complications After Right Lobe Living Donor Liver Transplantation
por: Kim, Min Seob, et al.
Publicado: (2022)

Liver Transplantation Beyond Milan Criteria
por: Lingiah, Vivek A, et al.
Publicado: (2020)

Sirolimus and Metformin Synergistically Inhibits Colon Cancer In Vitro and In Vivo
por: Mussin, Nadiar, et al.
Publicado: (2017)

Living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria: outcome of expanded criteria in tumor size
por: Liang, Hsin-Rou, et al.
Publicado: (2021)

Pure laparoscopic versus open right donor hepatectomy including the middle hepatic vein: a comparison of outcomes and safety
por: Park, Jae Hyun, et al.
Publicado: (2022)

Liver transplantation for hepatocellular carcinoma beyond the Milan criteria
por: Xu, Xiao, et al.
Publicado: (2016)

Factors associated with rituximab-mediated B cell depletion in ABO-incompatible adult living donor liver transplantation
por: Hong, Suk Kyun, et al.
Publicado: (2023)

Outcomes of Living Donor Liver Transplantation in Patients With a History of Ruptured Hepatocellular Carcinoma
por: Lee, Hwi Yeol, et al.
Publicado: (2021)

Bridging and downstaging role of trans-arterial radio-embolization for expected small remnant volume before liver resection for hepatocellular carcinoma
por: Shehta, Ahmed, et al.
Publicado: (2020)

Corrigendum: Bridging and downstaging role of trans-arterial radio-embolization for expected small remnant volume before liver resection for hepatocellular carcinoma
por: Shehta, Ahmed, et al.
Publicado: (2021)

Pure Laparoscopic vs. Open Right Hepatectomy in Living Liver Donors: Bench-Surgery Time
por: Hong, Kwangpyo, et al.
Publicado: (2021)

Living Donor Liver Transplantation: The Optimal Curative Treatment for Hepatocellular Carcinoma Even Beyond Milan Criteria
por: Alim, Altan, et al.
Publicado: (2021)

Changes in Indices of Steatosis and Fibrosis in Liver Grafts of Living Donors After Weight Reduction
por: Choi, Jaehyuk, et al.
Publicado: (2022)

Impact of Model for End-Stage Liver Disease allocation system on outcomes of deceased donor liver transplantation: A single-center experience
por: Park, Han Sang, et al.
Publicado: (2021)

Long-Term Survival Outcomes beyond the First Year after Liver Transplantation in Pediatric Acute Liver Failure Compared with Biliary Atresia: A Large-Volume Living Donor Liver Transplantation Single-Center Study
por: Lee, Sola, et al.
Publicado: (2022)

Pure Laparoscopic Versus Open Right Hepatectomy in Living Liver Donors: Graft Weight Discrepancy
por: Seo, Jiwon, et al.
Publicado: (2022)

Living Donor Liver Transplantation for an Infant with Osteogenesis Imperfecta and Intrahepatic Cholestasis: Report of a Case
por: Choi, YoungRok, et al.
Publicado: (2014)

Korean Patients Undergoing Deceased Donor Liver Transplantation for Alcoholic Liver Disease Have Non-Inferior Survival Outcomes than for Hepatitis B Virus: a Real-World Experience without Minimum Abstinence before Transplantation
por: Hong, Suk Kyun, et al.
Publicado: (2017)

Sarcopenia as a predictor of post-transplant tumor recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria
por: Kim, Young Ri, et al.
Publicado: (2018)

Outcomes of Split Liver Transplantation vs Living Donor Liver Transplantation in Pediatric Patients: A 5-Year Follow-Up Study in Korea
por: Yoon, Kyung Chul, et al.
Publicado: (2022)

Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome
por: Kornberg, A.
Publicado: (2014)

Liver Transplantation in Patients with Hepatocellular Carcinoma beyond the Milan Criteria: A Comprehensive Review
por: Toniutto, Pierluigi, et al.
Publicado: (2021)

Optimal Tailored Screening Protocol after Living Donor Liver Transplantation for Hepatocellular Carcinoma
por: Park, Min-Su, et al.
Publicado: (2014)

Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation
por: Kim, Hyeyoung, et al.
Publicado: (2014)

Impact of extended-criteria donor lungs according to preoperative recipient status and age in lung transplantation
por: Suh, Jee Won, et al.
Publicado: (2020)

Long-term outcomes of liver transplantation using grafts from donors with active hepatitis B virus replication: a multicenter cohort study
por: Gang, Sujin, et al.
Publicado: (2023)

Chemoembolization combined radiofrequency ablation vs. chemoembolization alone for treatment of beyond the Milan criteria viable hepatocellular carcinoma (CERFA): study protocol for a randomized controlled trial
por: Lee, Soon Kyu, et al.
Publicado: (2023)

Peri-Transplant Change in AFP Level: a Useful Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation
por: Yoo, Tae, et al.
Publicado: (2016)

Risk Factors Affecting Outcomes in Pediatric Liver Transplantation: A Real-World Single-Center Experience
por: Hong, Suk Kyun, et al.
Publicado: (2021)

Does living liver donors’ underestimation about surgical outcomes impact on their health-related quality of life after donation?: a descriptive cross-sectional study
por: Lee, Ye Sol, et al.
Publicado: (2022)

International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria
por: Degroote, Helena, et al.
Publicado: (2021)

Acute appendicitis after liver transplantation: A single center experience and review of the literature
por: Jamtani, Indah, et al.
Publicado: (2020)

Fatigue and related factors after liver transplantation
por: Hong, Kwangpyo, et al.
Publicado: (2015)

Heterogeneous living donor hepatic fat distribution on MRI chemical shift imaging
por: Choi, YoungRok, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_g0bt7o6iqo84janos07i8tt2vo